Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OpGen : Launches $15 Million Registered Direct Offering

10/14/2021 | 09:01am EST


ę MT Newswires 2021
All news about OPGEN, INC.
12/01OPGEN : Corporate Presentation (PDF)
PU
11/30OPGEN : Subsidiary Ares Genetics Announces Strategic Database Access Transaction - Form 8-..
PU
11/30OPGEN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/30OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
GL
11/12OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update - Form ..
PU
11/11OpGen, Inc. Provides Revenue Guidance for the Year 2021
CI
11/11Earnings Flash (OPGN) OPGEN Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M
MT
11/11OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/11OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
11/04OpGen Corporate Presentation (PDF)
PU
More news
Analyst Recommendations on OPGEN, INC.
More recommendations
Financials (USD)
Sales 2021 3,80 M - -
Net income 2021 -35,9 M - -
Net cash 2021 8,88 M - -
P/E ratio 2021 -1,49x
Yield 2021 -
Capitalization 57,6 M 57,6 M -
EV / Sales 2021 12,8x
EV / Sales 2022 8,71x
Nbr of Employees 102
Free-Float 99,7%
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,48 $
Average target price 4,18 $
Spread / Average Target 182%
EPS Revisions
Managers and Directors
Oliver Schacht President, Chief Executive Officer & Director
William E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
Faranak Atrzadeh Chief Marketing & Scientific Affairs Officer
Johannes Bacher Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
OPGEN, INC.-27.45%58
MODERNA, INC.197.32%125 937
LONZA GROUP AG28.34%58 955
IQVIA HOLDINGS INC.44.70%49 527
SEAGEN INC.-9.64%28 937
CELLTRION, INC.-40.67%24 625